Howard Scher

Howard I. Scher is the Chief of the Genitourinary Oncology at Memorial Sloan Kettering Cancer Center and Professor of Medicine at the Weill Cornell Medical College. He has a depth of experience in clinical trials for novel types of cancer treatment.[1]

Early life and education

Scher earned his BS from Bates College and his MD from New York University School of Medicine before doing his residency at Bellevue Hospital.[2] He married Deborah Ann Lafer in 1989.[3]

Career

Scher has been an investigator at Memorial Sloan Kettering Cancer Center since 1992 and Professor of Medicine at the Weill Cornell Medical College.[4] His areas of research include PI3K, the androgen receptor, HSP90, and immunotherapy.

Scher is on the board of directors at Asterias, a biotechnology company.[5]

Scher was awarded American Association for Cancer Research's 2015 Team Science Award along with Michael E. Jung and Charles Sawyers for their work in the development of enzalutamide.[6] He has also collaborated with Brett Carver and Neal Rosen, both also at MSKCC, on experimental cancer therapeutics for androgen-resistance prostate cancer.[7]

Scher has published over 500 scholarly works.

He is not known for treating patients, possibly because he travels extensively, addressing medical conferences. For instance, in the case of one man whose prostate cancer had spread, Dr. Scher met with him once for 45 minutes at the beginning of a year, during the course of which year the patient's PSA tests were lost or ignored; rises in his PSA went un-noticed and the individual received no treatment. Within 9 months, the man's PSA was doubling every month, but no treatment was offered. The patient's requests for information and call-backs went ignored. The patient himself then discovered that his PSA reports had gone astray and that they had not had not been pursued, nor attempts made to locate them. At the end of a second month of doubling PSA the individual had had an MRI on his local internist's recommendation. The patient followed up the MRI with Dr. Scher, who was again away. He was read a report by a secretary, which neither she nor he understood, so he insisted she get a physician to interpret the MRI to him. This physician was not forthcoming with accessible information and recommended no course of action.

References

  1. ↑ "Medscape Log In". Retrieved 3 December 2016.
  2. ↑ "Howard I. Scher M.D.: Executive Profile & Biography - Bloomberg". Retrieved 3 December 2016.
  3. ↑ "Deborah Lafer to Wed Dr. Howard I. Scher". The New York Times. 1 January 1989. Retrieved 3 December 2016.
  4. ↑ "Howard I. Scher - Memorial Sloan Kettering Cancer Center". Retrieved 3 December 2016.
  5. ↑ "Howard I. Scher M.D., Leading Clinical Oncology Expert, Joins the Board of Directors of Asterias Biotherapeutics". Retrieved 3 December 2016.
  6. ↑ "Michael E. Jung, PhD, Charles Sawyers, MD, and Howard I. Scher, MD, Receive Team Science Award From American Association for Cancer Research - The ASCO Post". Retrieved 3 December 2016.
  7. ↑ "Howard Scher, MD - Prostate Cancer Foundation". Retrieved 3 December 2016.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.